Figure 1. Decline in plasma concentrations of [Greek small letter epsilon]-aminocaproic acid (EACA) after a single 30 mg/kg (group I) or 100 mg/kg (group II) dose administered after cardiopulmonary bypass (CPB). Data are plotted on a semilog scale. The two dose groups could be described by the same elimination model, confirming dose-independence of kinetics. Blood samples were collected as described in Table 3.